Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00054275 Information provided by Case Comprehensive Cancer Center

First Received: February 5, 2003 Last Updated: November 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2015
Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)